Show simple item record

dc.contributor.authorDiaz, Abbey
dc.contributor.authorKang, Jimin
dc.contributor.authorMoore, Suzanne P
dc.contributor.authorBaade, Peter
dc.contributor.authorLangbecker, Danette
dc.contributor.authorCondon, John R
dc.contributor.authorValery, Patricia C
dc.date.accessioned2021-09-07T05:38:32Z
dc.date.available2021-09-07T05:38:32Z
dc.date.issued2017
dc.identifier.issn1877-7821
dc.identifier.doi10.1016/j.canep.2016.12.010
dc.identifier.urihttp://hdl.handle.net/10072/407711
dc.description.abstractBackground: Comorbidity is associated with poor outcomes for cancer patients but it is less clear how it influences cancer prevention and early detection. This review synthesizes evidence from studies that have quantified the association between comorbidity and participation in breast and cervical screening. Methods: PubMed, CINAHL and EMBASE databases were systematically searched using key terms related to cancer screening and comorbidity for original research articles published between 1 January 1991 and 21 March 2016. Two reviewers independently screened 1283 studies that met eligibility criteria related to Population (adult, non-cancer populations), Exposure (comorbidity), Comparison (a ‘no comorbidity’ group), and Outcome (participation in breast cancer or cervical screening). Data was extracted and risk of bias assessed using a standardised tool from the 22 studies identified for inclusion (17 breast; 13 cervical). Meta-analyses were performed for participation in breast and cervical screening, stratified by important study characteristics. Results: The majority of studies were conducted in the United States. Results of individual studies were variable. Most had medium to high risk of bias. Based on the three “low risk of bias” studies, mammography screening was less common among those with comorbidity (pooled Odds Ratio 0.66, 95%CI 0.44–0.88). The one “low risk of bias” study of cervical screening reported a negative association between comorbidity and participation. Conclusion: While a definitive conclusion could not be drawn, the results from high quality studies suggest that women with comorbidity are less likely to participate in breast, and possibly cervical, cancer screening.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherElsevier
dc.relation.ispartofpagefrom7
dc.relation.ispartofpageto19
dc.relation.ispartofjournalCancer Epidemiology
dc.relation.ispartofvolume47
dc.subject.fieldofresearchOncology and carcinogenesis
dc.subject.fieldofresearchHealth services and systems
dc.subject.fieldofresearchPublic health
dc.subject.fieldofresearchcode3211
dc.subject.fieldofresearchcode4203
dc.subject.fieldofresearchcode4206
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsOncology
dc.subject.keywordsPublic, Environmental & Occupational Health
dc.subject.keywordsComorbidity
dc.titleAssociation between comorbidity and participation in breast and cervical cancer screening: A systematic review and meta-analysis
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationDiaz, A; Kang, J; Moore, SP; Baade, P; Langbecker, D; Condon, JR; Valery, PC, Association between comorbidity and participation in breast and cervical cancer screening: A systematic review and meta-analysis, Cancer Epidemiology, 2017, 47, pp. 7-19
dcterms.dateAccepted2016-12-22
dc.date.updated2021-09-07T05:36:48Z
gro.hasfulltextNo Full Text
gro.griffith.authorBaade, Peter D.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record